Cargando…
Patients’ Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study
Objectives: Giant cell arteritis (GCA) is associated with severe outcomes such as infections and cardiovascular diseases. We describe here the impact of GCA patients’ characteristics and treatment exposure on the occurrence of severe outcomes. Methods: Data were collected retrospectively from real-w...
Autores principales: | Dumain, Cyril, Broner, Jonathan, Arnaud, Erik, Dewavrin, Emmanuel, Holubar, Jan, Fantone, Myriam, de Wazières, Benoit, Parreau, Simon, Fesler, Pierre, Guilpain, Philippe, Roubille, Camille, Goulabchand, Radjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181652/ https://www.ncbi.nlm.nih.gov/pubmed/35683507 http://dx.doi.org/10.3390/jcm11113115 |
Ejemplares similares
-
Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database
por: Goulabchand, Radjiv, et al.
Publicado: (2021) -
Use of high-plex data provides novel insights into the temporal artery processes of giant cell arteritis
por: Parreau, Simon, et al.
Publicado: (2023) -
Hospitalization Risks for Neurological Disorders in Primary Sjögren’s Syndrome Patients
por: Goulabchand, Radjiv, et al.
Publicado: (2022) -
Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013) -
Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)